Please login to the form below
Belgium
This page shows the latest Belgium news and features for those working in and with pharma, biotech and healthcare.
Longitude Prize in final stage of deciding recipients of £8m prize
50 teams are actively pursuing the Longitude Prize currently and are based in the UK, the US, Canada, Australia, Israel, Sweden, the Netherlands, Belgium, India, Turkey and Malaysia.
Latest news
-
Moderna appoints Jorge Gomez as chief financial officer
Gomez also held financial and business leadership roles at General Motors, working internationally in New York City, Belgium, Singapore and Brazil.
-
Muna raises $73m to advance neurodegenerative disease-focused small molecule pipeline
The team then united with K5 Therapeutics – co-founded in 2020 by Bart De Stropper of VIB-KU Leuven Belgium – and the combined company will now be based in both Copenhagen
-
GCI Health opens new office in Brussels
Healthcare and medical communications agency GCI Health has opened a new office in Brussels, Belgium to expand its global public affairs offering.
-
bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
Nine patients from seven countries (Italy, France, Germany, Greece, Cyprus, Belgium and the Netherlands), each representing different life stages between the ages of 4 and 61, feature in an 11-minute ... It is especially prevalent in countries like Italy,
-
J&J completes enrolment for late-stage COVID-19 vaccine trial
This trial is currently enrolling participants in Belgium, Colombia, France, Germany, the Philippines, South Africa, Spain, the UK and US.
More from news
Approximately 2 fully matching, plus 199 partially matching documents found.
Latest Intelligence
-
Piloting a route to the biosimilars opportunities in Europe
In addition, Belgium, Germany and Sweden have all introduced government policies to provide incentives for manufacturers, hospitals and patients.
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Ireland proposed extending vaccination to all children aged 2 to 17, while Belgium, one of the countries hit hardest in terms of COVID-19 death rates, recommended vaccinating everyone between the
-
Multichannel engagement and the need for greater understanding of European markets
Some markets present a more significant challenge. In Belgium, there is a greater reliance on face-to-face meetings with sales reps, whereas, in the UK and France, physicians are generally ... Half had no strong beliefs either way. France and the UK show
-
20 for 2020 – Five pharma leaders to watch in 2020
5. Onno van de Stolpe – Galapagos’ dealmaker. Last on our list is Onno van de Stolpe, the Dutch chief executive of Belgium-based biotech Galapagos.
-
As the opioid crisis grabs the headlines, the search for safe treatments continues
lower. There is no reason why such an effective treatment should not reach coverage levels of 65-85% as they do in France, Switzerland and Belgium which experience lower rates of
More from intelligence
Approximately 1 fully matching, plus 27 partially matching documents found.
Latest appointments
-
Health comms agency emotive hires new cell and gene therapy leader
scientific institutions across the globe, including Singapore, Switzerland, London, Belgium, theUS and Italy.
-
Ablynx reshuffles its board again
Dr Bo Jesper Hansen resigns from the Belgium biotech's board. After one month as Ablynx’s chairman of the board of directors, Dr Bo Jesper Hansen (pictured) has resigned from
-
MedTech Europe appoints new board of directors
Medical technology European trade association MedTech Europe appointed a new board of directors at its recent general assembly in Brussels, Belgium.
-
Belgium's TiGenix appoints Dr Gregory Gordon
Belgium biopharma firm TiGenix has appointed Dr Gregory Gordon to head up its US medical department as part of moves to strengthen its stateside operations.
-
Vintura appoints Lieven Annemans as an associate partner
The professor teaches in the faculty of medicine and health sciences at Ghent University based in Belgium and he is also president of the Flemish Healthcare council.
More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
Wedgewood Communications joins imc group to expand its presence in the US market
Waterland manages 8 billion in funds and has teams based in the UK, Ireland, France, the Netherlands, Belgium, Germany, Poland, Switzerland and Denmark, and operates across Europe.
-
Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical
Waterland manages 8 billion in funds and has teams based in the United Kingdom, Ireland, France, Netherlands, Belgium, Germany, Poland, Switzerland, and Denmark, and operates across Europe.
-
The UK has approved the first vaccine for COVID-19. What now?
Supply is on its way from Belgium and so the rate limiting step is most likely how fast can we vaccinate rather than how fast can the vaccine be produced.
-
Impetus Digital Fireside Chat with Deloitte Europe: The Future of Learning
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as
-
More tell, less sell: HCP-centric comms
15. Across Health. Multichannel Maturometer 2017. Gent, Belgium: 2017. 16. Publicis Touchpoint Solutions.
More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
